LifeMD Inc reports results for the quarter ended in December - Earnings Summary

LifeMD

22/03/2023 21:01

* LifeMD Inc  LFMD.OQ  reported a quarterly adjusted loss
of 40
cents​​ per share for the quarter ended in December. The lone
analyst forecast for the quarter was for a loss of 18 cents per
share.
    * Revenue rose 2.6% to $28.12 million from a year ago;
analysts
expected $33.60 million. 
    * LifeMD Inc's reported EPS for the quarter was a loss of 40
cents​.
    * The mean earnings estimate of analysts had risen by
about 10% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * LifeMD Inc shares had fallen by 39.7% this quarter.
    * The company reported a quarterly loss of $12.71 million.
    * Wall Street's median 12-month price target for LifeMD Inc
is
$8.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 22 at 09:00 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.18          -0.40          Missed
 Sep. 30 2022      -0.28          -0.26          Beat
 Jun. 30 2022      -0.35          -0.45          Missed
 Mar. 31 2022      -0.36          -0.46          Missed